Skip to search.
 FTSE 100 Down 0.71%

Kite Pharma, Inc. (KITE)

-NasdaqGS
66.88 Up 1.91(2.94%) 20:09 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:64.97
Open:65.00
Bid:66.78 x 100
Ask:66.95 x 100
1y Target Est:84.00
Beta:N/A
Next Earnings Date:N/A
Day's Range:64.55 - 67.50
52wk Range:21.00 - 89.21
Volume:696,215
Avg Vol (3m):1,309,230
Market Cap:2.80b
P/E (ttm):N/A
EPS (ttm):-2.33
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
KITEUp 2.94%2.80b
CELGDown 2.11%94.60b
NVSDown 1.31%234.23b
PFEDown 1.26%208.60b

Key Statistics

Forward P/E (1 yr):101.35
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.79
Quarterly EPS Est (Dec-14) :-0.20
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Kite Pharma, Inc. operates a clinical-stage biopharmaceutical company which focuses on the development and commercialization of novel cancer immunotherapy products. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback